Karus Therapeutics Ltd, a company developing small-molecule drugs to treat cancer and inflammation, announced recently that it has signed an agreement to collaborate with Professor Bart Vanhaesebroeck at Queen Mary, University of London.
29 September, 2009
AstraZeneca and Nektar Therapeutics announced recently that they have entered into a worldwide license agreement for two drug development programmes: NKTR-118, a late-stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early-stage programme that is intended to deliver products for the treatment of pain without constipation side-effects.
24 September, 2009
Further pain reduction on duloxetine shown during study’s extension phase.
14 September, 2009
As the 20th Drug Delivery to the Lungs (DDL) conference approaches, DDL Chairman Sandy Munro offers his view on what he anticipates to be the highlights for this year’s conference; including the aims to maintain the Drug Delivery to the Lungs (DDL) technical focus while broadening its horizons. He will also be previewing what's in store for this year's special anniversary event.
09 September, 2009